In:
Cancer, Wiley, Vol. 126, No. 21 ( 2020-11), p. 4780-4787
Abstract:
In the current study, the authors report what, to the best of their knowledge, is the largest single‐center analysis of the safety and efficacy of immune checkpoint inhibitors after solid organ transplantation published to date. The results indicate that selected solid organ transplant recipients with metastatic cancers may benefit from treatment with checkpoint inhibitors, but more studies are needed to determine how best to use these agents to improve outcomes further.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v126.21
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1